MARKET

URGN

URGN

Urogen Pharma
NASDAQ
24.28
-0.07
-0.29%
After Hours: 23.89 -0.39 -1.61% 19:06 12/04 EST
OPEN
24.42
PREV CLOSE
24.35
HIGH
24.92
LOW
23.92
VOLUME
715.57K
TURNOVER
--
52 WEEK HIGH
30.00
52 WEEK LOW
3.420
MARKET CAP
1.14B
P/E (TTM)
-7.3353
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at URGN last week (1124-1128)?
Weekly Report · 3d ago
UroGen Pharma: Strong Potential As Zusduri Commercialization Accelerates
Seeking Alpha · 11/25 13:30
Weekly Report: what happened at URGN last week (1117-1121)?
Weekly Report · 11/24 10:30
Weekly Report: what happened at URGN last week (1110-1114)?
Weekly Report · 11/17 10:30
UroGen Pharma’s Promising Outlook: Buy Rating Backed by ZUSDURI’s Growth and Strong Financial Health
TipRanks · 11/10 11:25
Weekly Report: what happened at URGN last week (1103-1107)?
Weekly Report · 11/10 10:27
UroGen Pharma’s Earnings Call: Growth Amid Challenges
TipRanks · 11/08 01:07
Ladenburg Thalmann & Co. Sticks to Its Buy Rating for Urogen Pharma (URGN)
TipRanks · 11/07 16:37
More
About URGN
UroGen Pharma Ltd. Is an Israel-based biopharmaceutical company. The Company is engaged in building solutions for cancers and urologic diseases. UroGen has developed RTGelTM reverse-thermal hydrogel, a proprietary sustained release, hydrogel-based platform technology that has the potential to improve therapeutic profiles of existing drugs. Its lead product candidates include MitoGel and VesiGel are formulated using its proprietary reverse thermally triggered hydrogel, or RTGel, technology. MiroGel ( UGN-101) is a sustained release formulation of the chemotherapy agent Mitomycin C for the treatment of low-grade upper tract urothelial carcinoma, an urothelial cancer in the upper tract. VesiGel (UGN-102) is a sustained release formulation of a high dose Mitomycin C for the treatment of low grade non-muscle invasive bladder cancer (LG-NMIBC).

Webull offers Urogen Pharma Ltd stock information, including NASDAQ: URGN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, URGN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading URGN stock methods without spending real money on the virtual paper trading platform.